SOLIGENIX, INC. — Director's Dealing 2009

Oct 13, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX.OB)
CIK: 0000812796
Period of Report: 2009-10-09

Reporting Person: Biotex Pharma Investments, LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-10-09	Common Stock	D	335000	$.317	Disposed	17665000	Direct